NCT06297707

Brief Summary

PURPOSE: to evaluate effect of aquatic high intensity resistive training on cardiac function and exercise capacity in patients with chronic heart failure. BACKGROUND: Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of \>37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many etiologies, and patients with HF experience numerous symptoms that affect their quality of life, including dyspnea, fatigue, poor exercise tolerance, and fluid retention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

March 5, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 7, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

July 23, 2024

Status Verified

July 1, 2024

Enrollment Period

1.1 years

First QC Date

February 22, 2024

Last Update Submit

July 21, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac function

    echocardiogram Left ventricular systolic dysfunction will be assessed using the ejection fraction by 2D simpson method (the percentage of the end diastolic volume ejected during systole

    12 weeks

Secondary Outcomes (2)

  • exercise capacity

    12 weeks

  • physical symptoms of heart failure

    12 weeks

Study Arms (2)

experimental group

EXPERIMENTAL

aquatic high intensity resistive training

Other: aquatic high intensity resistive training

control group

ACTIVE COMPARATOR

usual care

Other: usual care

Interventions

The experimental group participants will involve in aquatic high intensity resistive training sessions. The participants in the intervention group will receive 1 h of supervised lower limb aquatic resistance training three times a week for 12 weeks, for a total of 36 training sessions.

experimental group

The control group will maintain usual care and will be asked to continue their usual leisure time activities. They will be offered the possibility of participating in two sessions consisting of 1 h of light stretching and relaxation during the 3-month intervention period.

control group

Eligibility Criteria

Age45 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age ranges from 45 to 60 years old. Have chronic heart failure (NYHA class I to III).
  • Left ventricular ejection fraction (LVEF) \> 50%
  • clinically stable with optimal pharmacological therapy in greater than three months
  • All patients didn't participate in any rehabilitation programs prior to the study.

You may not qualify if:

  • Signs of acute heart failure, unstable angina, or severe arrhythmia three months prior to enrolment in the study.
  • Pacemakers. recently diagnosed acute coronary syndrome or a recent coronary intervention or both renal insufficiency (estimated glomerular filtration rate \< 30 mL/min) liver abnormalities uncontrolled hypertension moderate-to-severe valvular disease uncompensated heart failure patients Chronic lung disease. Other disorders counteracting exercise conditions that limit lower limb mobility (for example, burns, fractures)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy

Cairo, Dokki, 11432, Egypt

RECRUITING

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • marwa elsayed

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

marwa elsayed, PhD

CONTACT

marwa elsayed

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

February 22, 2024

First Posted

March 7, 2024

Study Start

March 5, 2024

Primary Completion

March 30, 2025

Study Completion

December 30, 2025

Last Updated

July 23, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

sharing study protocol with other researches

Shared Documents
STUDY PROTOCOL
Time Frame
2 years
Access Criteria
acceptance the publishing journal
More information

Locations